Potassium Levels in COVID Subjects: Current Observations and New Possibilities for its use in COVID Diagnosis

α
Sriram Padmanabhan
Sriram Padmanabhan

Send Message

To: Author

Potassium Levels in COVID Subjects: Current Observations and New Possibilities for its use in COVID Diagnosis

Article Fingerprint

ReserarchID

XC6LU

Potassium Levels in COVID Subjects: Current Observations and New Possibilities for its use in COVID Diagnosis Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causing covid infection in humans is a major global threat to healthcare and economy. According to the recent statistics of the World Health Organization (WHO), the disease has already involved all continents, with almost 117,498,522 cases with more than 2,606,626 deaths all over the globe until March 2021. It is thus, imperative to study and develop pharmacological treatments suitable for the prevention and treatment of COVID-19. The COVID causing virus is mainly transmitted through cough or sneeze droplets generated by an infected person. Hence its early and accurate diagnosis appears essential for minimizing spread, prevention and eventually containment of the pandemic. Also, since the clinical presentation of the COVID infection is varied starting from asymptomatic to severe cases, it reinforces the need for detection methods that are simple, early and with good sensitivity and specificity. This article reviews impact of potassium ions in functioning of various organs in humans and its possible role in COVID disease progression.

References

83 Cites in Article
  1. Hussin Rothan,Siddappa Byrareddy (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.
  2. J Cui,F Li,Z Shi (2019). Origin and evolution of pathogenic coronaviruses.
  3. U Jain (2020). Effect of covid-19 on the organs.
  4. Oscar Moreno-Pérez,Jose-Manuel Leon-Ramirez,Laura Fuertes-Kenneally,Miguel Perdiguero,Mariano Andres,Mar Garcia-Navarro,Paloma Ruiz-Torregrosa,Vicente Boix,Joan Gil,Esperanza Merino,Santos Asensio,Cleofé Fernandez,Alfredo Candela,Mª Del Mar García,Rosario Sánchez,Sergio Reus,Paloma Ruiz,Raquel García-Sevila,María-Ángeles Martínez,María-Mar García-Mullor,Mar Blanes,Jaime Guijarro,José Pascual,Iris Gonzalez,Pedro Sanso,José Ramos,Jaime Javaloy,Clara Llopis,Olga Coronado,Esther García,Gonzalo Rodríguez,Paola Melgar,Mariano Franco,Félix Lluís,Carmen Zaragoza,Cándido Alcaraz,Ana Carrión,Celia Villodre,Emilio De La Cuesta,Cristina Alenda,Francisca Peiró,María Planelles,Laura Greco,Sandra Silvia,Antonio Francia,Iván Verdú,Juan Sales,Ana Palacios,Hortensia Ballester,Antonio García-Valentín,Marta Márquez,Eva Canelo,Andrea Juan,Elena Vives (2020). Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients.
  5. Giuseppe Lippi,Andrew South,Brandon Henry (2020). Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19).
  6. Biff Palmer,Deborah Clegg (2016). Physiology and pathophysiology of potassium homeostasis.
  7. Robson Santos,Anderson Ferreira,Ana Simões E Silva (2008). Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis.
  8. M Weir,Rolfe (2010). Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
  9. Dawei Wang,Bo Hu,Chang Hu,Fangfang Zhu,Xing Liu,Jing Zhang,Binbin Wang,Hui Xiang,Zhenshun Cheng,Yong Xiong,Yan Zhao,Yirong Li,Xinghuan Wang,Zhiyong Peng (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China.
  10. Alvin Levine,Phyllis Bond,A Scala,Monroe Eaton (1956). Studies on the Relationship of Potassium to Influenza Virus Multiplication.
  11. B Choi,P Gatti,A Haislip (1998). Role of potassium in human immunodeficiency virus production and cytopathic effects.
  12. Emma Punch,Samantha Hover,Henry Blest,Jack Fuller,Roger Hewson,Juan Fontana,Jamel Mankouri,John Barr (2018). Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus.
  13. Manish Gutch,Avinash Agarwal,Amrendra Amar (2012). Hypokalemic quadriparesis: An unusual manifestation of dengue fever.
  14. Rebecca Chandler (2018). Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?.
  15. Paulo Pimenta,Claudia Silva,François Noël (2010). Ivermectin is a nonselective inhibitor of mammalian P-type ATPases.
  16. R Arise,S Malomo (2009). Effects of ivermectin and albendazole on some liver and kidney function indices in rats.
  17. Leon Caly,Julian Druce,Mike Catton,David Jans,Kylie Wagstaff (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
  18. Lisa Oestereich,Anja Lüdtke,Stephanie Wurr,Toni Rieger,César Muñoz-Fontela,Stephan Günther (2014). Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
  19. Pierangelo Chinello,Nicola Petrosillo,Silvia Pittalis,Gianluigi Biava,Giuseppe Ippolito,Emanuele Nicastri (2017). QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
  20. H Mabillard,J Sayer (1000). Electrolyte disturbances in SARS-CoV-2 infection.
  21. Andrés Pizzorno,Blandine Padey,Thomas Julien,Sophie Trouillet-Assant,Aurélien Traversier,Elisabeth Errazuriz-Cerda,Julien Fouret,Julia Dubois,Alexandre Gaymard,François-Xavier Lescure,Victoria Dulière,Pauline Brun,Samuel Constant,Julien Poissy,Bruno Lina,Yazdan Yazdanpanah,Olivier Terrier,Manuel Rosa-Calatrava (2020). Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia.
  22. Yeming Wang,Dingyu Zhang,Guanhua Du,Ronghui Du,Jianping Zhao,Yang Jin,Shouzhi Fu,Ling Gao,Zhenshun Cheng,Qiaofa Lu,Yi Hu,Guangwei Luo,Ke Wang,Yang Lu,Huadong Li,Shuzhen Wang,Shunan Ruan,Chengqing Yang,Chunlin Mei,Yi Wang,Dan Ding,Feng Wu,Xin Tang,Xianzhi Ye,Yingchun Ye,Bing Liu,Jie Yang,Wen Yin,Aili Wang,Guohui Fan,Fei Zhou,Zhibo Liu,Xiaoying Gu,Jiuyang Xu,Lianhan Shang,Yi Zhang,Lianjun Cao,Tingting Guo,Yan Wan,Hong Qin,Yushen Jiang,Thomas Jaki,Frederick Hayden,Peter Horby,Bin Cao,Chen Wang (2020). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
  23. Rakesh Yadav,Ragav Bansal,Sudhanshu Budakoty,Parag Barwad (2020). COVID-19 and sudden cardiac death: A new potential risk.
  24. Tao Guo,Yongzhen Fan,Ming Chen,Xiaoyan Wu,Lin Zhang,Tao He,Hairong Wang,Jing Wan,Xinghuan Wang,Zhibing Lu (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
  25. N Krstic-Pavlovic,R Zamic,S Jelacic (1992). POTASSIUM CONTENTS IN SOME MEDICINAL PLANTS.
  26. P Shree,P Mishra,C Selvaraj (2020). Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -Withaniasomnifera (Ashwagandha), Tinosporacordifolia (Giloy) and Ocimum sanctum (Tulsi) -a molecular docking study.
  27. S Shimmi,N Jahan,N Sultana (2012). Effects of Ashwagandha (Withaniasomnifera) root extract against gentamicin induced changes of serum electrolytes in rats.
  28. Ashish Sharma,Kunal Kishore,Divya Sharma,B Srinivasan,Shyam Agarwal,Ashok Sharma,Santosh Singh,Samir Gaur,Vijay Jatav (2011). Cardioprotective activity of alcoholic extract of Tinospora cordifolia (Willd.) Miers in calcium chloride-induced cardiac arrhythmia in rats.
  29. Woosang Jung,Seungwon Kwon,Jinwook Im,Seonguk Park,Sangkwan Moon,Jungmi Park,Changnam Ko,Kiho Cho (2014). Influence of Herbal Complexes Containing Licorice on Potassium Levels: A Retrospective Study.
  30. E Williamson,S Driver,K Baxter (2009). Stockley's Herbal Medicines Interactions.
  31. Alladi Mohan,Raya Premanand,Lebaka Reddy,Mangu Rao,Surendra Sharma,Ranjit Kamity,Srinivas Bollineni (2006). Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit.
  32. N Telfer,J Weiner,Q Merrill (1975). Distribution of sodium and potassium in chronic obstructive pulmonary disease.
  33. P Das,M Bandyopadhyay,K Baral (2010). Dyselectrolytemia in Chronic obstructive pulmonary diseases with acute exacerbation.
  34. Sameh Maklad,Fareed Basiony (2019). Electrolyte disturbances in patients with acute exacerbation of chronic obstructive pulmonary disease.
  35. D Sparrow,O' Connor,G Rosner,B (1991). Methacholine airway responsiveness and 24-hour urine excretion of sodium and potassium. The Normative Aging Study.
  36. F Gilliland,K Berhane,Y Li (2002). Dietary Magnesium, Potassium, Sodium, and Children's Lung Function.
  37. T Gustafson,K Boman,L Rosenhall (1996). Skeletal muscle magnesium and potassium in asthmatics treated with oral beta(2)-agonists.
  38. P Fantidis,C Ruiz,M Marin (1995). Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks.
  39. Omer Alamoudi (2001). Electrolyte Disturbances in Patients With Chronic, Stable Asthma.
  40. A Awasthi,S Malik,H Khalili (2017). Identification and characterization of a novel association between dietary potassium and risk of Crohn's disease and ulcerative colitis.
  41. Sandeep Goyal,Ritika Rampal,Saurabh Kedia,Sandeep Mahajan,Sawan Bopanna,Devesh Yadav,Saransh Jain,Amit Singh,Md. Wari,Govind Makharia,Amit Awasthi,Vineet Ahuja (2017). Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role.
  42. T Kianifard,A Chopra (2918). A therapeutic role for potassium (K) to reduce pain and complications related to the cardiovascular system and bone in rheumatoid arthritis (RA): A clinical research perspective.
  43. John Funder,Robert Carey,Franco Mantero,M Murad,Martin Reincke,Hirotaka Shibata,Michael Stowasser,William Young (2016). The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
  44. Naoki Nishiyama,Masako Takeshita,Kenichiro Tanaka,Mariko Miyao,Yuzo Mizuno (2011). A case of severe hypokalemia caused by a Chinese herbal remedy (Yokukansan) in an 81-year-old woman with dementia.
  45. Ravindrakumar Garg,Hardeepsingh Malhotra,Rajesh Verma,Pawan Sharma,Maneeshkumar Singh (2013). Etiological spectrum of hypokalemic paralysis: A retrospective analysis of 29 patients.
  46. Hassan Afridi,Tasneem Kazi,Farah Talpur,Naveed Kazi,Faheem Naeemullah,Sadaf Arain,Kapil Brahman (2013). Evaluation of Calcium, Magnesium, Potassium and Sodium in Biological Samples of Male Human Immunodeficiency Virus Patients with Tuberculosis and Diarrhea Compared to Healthy Control Subjects in Pakistan.
  47. V Khandelwal,V Patil,A Botre (2019). Electrolyte disturbances in dengue infected patients.
  48. Jsm Peiris,C Chu,Vcc Cheng (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.
  49. Z Li,M Wu,J Guo (2020). Caution on kidney dysfunctions of 2019-nCoV patients.
  50. D Gitlin,Hypokalemia,Hypomagnesemia (2006). Handbook of Medicine in Psychiatry.
  51. Betty Pfefferbaum,Carol North (2020). Mental Health and the Covid-19 Pandemic.
  52. K Kjeldsen (2010). Hypokalemia and sudden cardiac death.
  53. Lyanne Kieneker,Ron Gansevoort,Rudolf Boer,Frank Brouwers,Edith Feskens,Johanna Geleijnse,Gerjan Navis,Stephan Bakker,Michel Joosten (2016). Urinary potassium excretion and risk of cardiovascular events.
  54. T Tanaka,T Okamura,K Miura (2002). A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen.
  55. Terukazu Kawasaki,Kazue Itoh,Keiko Uezono,Haruka Sasaki (1993). A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTS.
  56. Ian Brown,Alan Dyer,Queenie Chan,Mary Cogswell,Hirotsugu Ueshima,Jeremiah Stamler,Paul Elliott (2013). Estimating 24-Hour Urinary Sodium Excretion From Casual Urinary Sodium Concentrations in Western Populations.
  57. P Godkar (2004). Determination of ions and automation.
  58. C Burtis,D Bruns (2008). Teitz Fundamentals of Clinical Chemistry.
  59. R Pistelli,F Forastiere,G Corbo,V Dell'orco,G Brancato,N Agabiti,A Pizzabiocca,C Perucci (1993). Respiratory symptoms and bronchial responsiveness are related to dietary salt intake and urinary potassium excretion in male children.
  60. Wenling Wang,Yanli Xu,Ruqin Gao,Roujian Lu,Kai Han,Guizhen Wu,Wenjie Tan (2020). Detection of SARS-CoV-2 in Different Types of Clinical Specimens.
  61. George Bwire,Mtebe Majigo,Belinda Njiro,Akili Mawazo (2021). Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis.
  62. Liang Peng,Jing Liu,Wenxiong Xu,Qiumin Luo,Dabiao Chen,Ziying Lei,Zhanlian Huang,Xuejun Li,Keji Deng,Bingliang Lin,Zhiliang Gao (2020). SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.
  63. Yun Ling,Shui-Bao Xu,Yi-Xiao Lin,Di Tian,Zhao-Qin Zhu,Fa-Hui Dai,Fan Wu,Zhi-Gang Song,Wei Huang,Jun Chen,Bi-Jie Hu,Sheng Wang,En-Qiang Mao,Lei Zhu,Wen-Hong Zhang,Hong-Zhou Lu (2020). Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
  64. Lakhvir Singh,Udeybir Singh,Ravikant Gupta,Aps Sethi (2018). Effect of Dietary Inclusion of Rice Distillers Dried Grains with Solubles with and without Enzyme on Growth Performance and Nutrient Metabolizability of Broilers.
  65. Nethajilokeswar Oburai,Vvaikunta Rao,Rambabu Bonath (2015). Comparative clinical evaluation of Boerhavia diffusa root extract with standard Enalapril treatment in Canine chronic renal failure.
  66. Mohammed Alnafiey,Abdullah Alangari,Abdullah Alarifi,Ahmed Abushara (2021). Persistent Hypokalemia post SARS-coV-2 infection, is it a life-long complication? Case report.
  67. A Kashi,Jdl Rosette,E Amini (2020). Urinary viral shedding of covid-19 and its clinical associations: A systematic review and meta-analysis of observational studies.
  68. Tomas Luther,Sara Bülow‐anderberg,Anders Larsson,Sten Rubertsson,Miklos Lipcsey,Robert Frithiof,Michael Hultström (2021). COVID‐19 patients in intensive care develop predominantly oliguric acute kidney injury.
  69. Alasdair Burns,Kwok Ho (2018). Urinary potassium excretion and its association with acute kidney injury in the intensive care unit.
  70. Yichun Cheng,Ran Luo,Kun Wang,Meng Zhang,Zhixiang Wang,Lei Dong,Junhua Li,Ying Yao,Shuwang Ge,Gang Xu (2020). Kidney disease is associated with in-hospital death of patients with COVID-19.
  71. Sérgio De Souza,Marcelo Silveira,Bruno De Freitas Souza,Carolina Nonaka,Erica De Melo,Julia Cabral,Fernanda Coelho,Rogério Da Hora Passos (2020). Evaluation of Urine SARS-COV-2 RT-PCR as a predictor of Acute Kidney Injury and disease severity in critical COVID-19 patients.
  72. Mohammad Taheri,Ali Bahrami,Parisa Habibi,Fatemeh Nouri (2020). A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19.
  73. Ekaterini Goudouris (2021). Laboratory diagnosis of COVID-19.
  74. Yi-Wei Tang,Jonathan Schmitz,David Persing,Charles Stratton (2020). Laboratory Diagnosis of COVID-19: Current Issues and Challenges.
  75. Jing Sun,Airu Zhu,Heying Li,Kui Zheng,Zhen Zhuang,Zhao Chen,Yongxia Shi,Zhaoyong Zhang,Si-Bei Chen,Xuesong Liu,Jun Dai,Xiaobo Li,Shuxiang Huang,Xiaofang Huang,Ling Luo,Liyan Wen,Jianfen Zhuo,Yuming Li,Yanqun Wang,Lu Zhang,Yanjun Zhang,Fang Li,Liqiang Feng,Xinwen Chen,Nanshan Zhong,Zifeng Yang,Jicheng Huang,Jincun Zhao,Yi-Min Li (2020). Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient.
  76. R Frithiof,A Bergqvist,J Jarhult (2020). Presence of SARS-Cov-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients.
  77. Y Liu,Y Yang,C Zhang (2020). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
  78. Lizhou Zhang,Cody Jackson,Huihui Mou,Amrita Ojha,Haiyong Peng,Brian Quinlan,Erumbi Rangarajan,Andi Pan,Abigail Vanderheiden,Mehul Suthar,Wenhui Li,Tina Izard,Christoph Rader,Michael Farzan,Hyeryun Choe (2020). SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
  79. S Laha,J Chakraborty,S Das (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
  80. (2020). Rapid Increase of a SAR-CoV-2 (COVID-19) Variant with Multiple Spike Protein Mutations.
  81. Adeel Afzal (2020). Molecular diagnostic technologies for COVID-19: Limitations and challenges.
  82. Gaetano Alfano,Annachiara Ferrari,Francesco Fontana,Rossella Perrone,Giacomo Mori,Elisabetta Ascione,Riccardo Magistroni,Giulia Venturi,Simone Pederzoli,Gianluca Margiotta,Marilina Romeo,Francesca Piccinini,Giacomo Franceschi,Sara Volpi,Matteo Faltoni,Giacomo Ciusa,Erica Bacca,Marco Tutone,Alessandro Raimondi,Marianna Menozzi,Erica Franceschini,Gianluca Cuomo,Gabriella Orlando,Antonella Santoro,Margherita Di Gaetano,Cinzia Puzzolante,Federica Carli,Andrea Bedini,Jovana Milic,Marianna Meschiari,Cristina Mussini,Gianni Cappelli,Giovanni Guaraldi (2021). Hypokalemia in Patients with COVID-19.
  83. Dong Chen,Xiaokun Li,Qifa Song,Chenchan Hu,Feifei Su,Jianyi Dai,Yinghai Ye,Jianping Huang,Xiaoming Zhang (2020). Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Sriram Padmanabhan. 2021. \u201cPotassium Levels in COVID Subjects: Current Observations and New Possibilities for its use in COVID Diagnosis\u201d. Global Journal of Medical Research - K: Interdisciplinary GJMR-K Volume 21 (GJMR Volume 21 Issue K4): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-K Classification: NLMC Code: WB 141
Version of record

v1.2

Issue date

May 30, 2021

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1924
Total Downloads: 939
2026 Trends
Related Research

Published Article

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causing covid infection in humans is a major global threat to healthcare and economy. According to the recent statistics of the World Health Organization (WHO), the disease has already involved all continents, with almost 117,498,522 cases with more than 2,606,626 deaths all over the globe until March 2021. It is thus, imperative to study and develop pharmacological treatments suitable for the prevention and treatment of COVID-19. The COVID causing virus is mainly transmitted through cough or sneeze droplets generated by an infected person. Hence its early and accurate diagnosis appears essential for minimizing spread, prevention and eventually containment of the pandemic. Also, since the clinical presentation of the COVID infection is varied starting from asymptomatic to severe cases, it reinforces the need for detection methods that are simple, early and with good sensitivity and specificity. This article reviews impact of potassium ions in functioning of various organs in humans and its possible role in COVID disease progression.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Potassium Levels in COVID Subjects: Current Observations and New Possibilities for its use in COVID Diagnosis

Sriram Padmanabhan
Sriram Padmanabhan

Research Journals